{"id":"epa-dha-alpha-tocopherol","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Fishy aftertaste"},{"rate":null,"effect":"Bleeding or bruising (at high doses)"}]},"_chembl":{"chemblId":"CHEMBL47","moleculeType":"Small molecule","molecularWeight":"430.72"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain omega-3 polyunsaturated fatty acids that modulate inflammatory pathways, reduce triglycerides, and improve endothelial function. Alpha-tocopherol (vitamin E) acts as an antioxidant to reduce oxidative stress. Together, these components work synergistically to improve lipid profiles and reduce cardiovascular risk.","oneSentence":"A combination of omega-3 fatty acids (EPA and DHA) and vitamin E that reduces inflammation and oxidative stress to support cardiovascular and metabolic health.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:11:02.827Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular disease prevention or management (Phase 3 indication under investigation)"}]},"trialDetails":[{"nctId":"NCT06129526","phase":"PHASE4","title":"Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes","status":"UNKNOWN","sponsor":"University of Ioannina","startDate":"2023-12","conditions":"Diabetes Type 2, Hypertriglyceridemia, Diabetes Mellitus","enrollment":450},{"nctId":"NCT05899660","phase":"NA","title":"Impact of Omega 3 in Alcohol Use Disorder","status":"RECRUITING","sponsor":"Université Catholique de Louvain","startDate":"2023-06-19","conditions":"Alcohol Use Disorder, Severe","enrollment":100},{"nctId":"NCT04844034","phase":"NA","title":"Effects of a High EPA Multinutrient Supplement on Negative Affect in Young Adults.","status":"UNKNOWN","sponsor":"University of Roehampton","startDate":"2022-04-19","conditions":"Anxiety, Depression","enrollment":94},{"nctId":"NCT02681601","phase":"NA","title":"Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer","status":"TERMINATED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2016-07-19","conditions":"Cancer of Pancreas","enrollment":2},{"nctId":"NCT04117022","phase":"NA","title":"Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG","status":"UNKNOWN","sponsor":"ZeaVision, LLC","startDate":"2019-09-01","conditions":"Diabetes, Diabetic Retinopathy","enrollment":45},{"nctId":"NCT01429454","phase":"PHASE1","title":"NAPLS Omega-3 Fatty Acid Versus Placebo Study","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-08","conditions":"Psychosis","enrollment":127},{"nctId":"NCT01087411","phase":"NA","title":"Intervention Study to Prevent Obesity in Sedentary 8 Year Old Swedish Children","status":"WITHDRAWN","sponsor":"Karolinska Institutet","startDate":"2008-10","conditions":"Cardiovascular Risk Factors, Metabolic Risk Factors, Sedentary Lifestyle","enrollment":""},{"nctId":"NCT00835289","phase":"NA","title":"The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial","status":"COMPLETED","sponsor":"Columbia University","startDate":"2009-03","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":40},{"nctId":"NCT01990690","phase":"PHASE4","title":"Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-01","conditions":"Oilgohydramnios","enrollment":202},{"nctId":"NCT03760757","phase":"NA","title":"Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men","status":"COMPLETED","sponsor":"Indiana University","startDate":"2019-02-11","conditions":"Inflammation; Muscle","enrollment":57},{"nctId":"NCT04156971","phase":"NA","title":"Effects of Omega-3 Supplementation on Nutritional Status and Physical Activity of Obese Children","status":"COMPLETED","sponsor":"Universiti Putra Malaysia","startDate":"2013-06-01","conditions":"Life Style Modification, Childhood Obesity","enrollment":37},{"nctId":"NCT01323283","phase":"NA","title":"Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2011-09","conditions":"Lifestyle-related Condition, Overweight and Obesity, Essential Fatty Acid Deficiency","enrollment":423},{"nctId":"NCT02231203","phase":"PHASE4","title":"Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function","status":"COMPLETED","sponsor":"Medical Center Alkmaar","startDate":"2014-10","conditions":"Colon Cancer","enrollment":44},{"nctId":"NCT01786239","phase":"NA","title":"Omega-3 Dietary Supplements in Schizophrenia","status":"COMPLETED","sponsor":"Delbert Robinson","startDate":"2013-05","conditions":"Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder","enrollment":50},{"nctId":"NCT01665742","phase":"NA","title":"Anti-inflammatory Dietary Intervention in Overweight and Obese Adolescents","status":"COMPLETED","sponsor":"University College Dublin","startDate":"2012-01","conditions":"Overweight, Obesity","enrollment":58},{"nctId":"NCT02229526","phase":"NA","title":"Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')","status":"COMPLETED","sponsor":"Sjurdur Frodi Olsen","startDate":"1990-01","conditions":"Preterm Birth, Intrauterine Growth Retardation, Pregnancy Induced Hypertension","enrollment":1619},{"nctId":"NCT01842191","phase":"PHASE4","title":"Efficacy of Fish Oil in Multiple Sclerosis","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2010-05","conditions":"Relapsing- Remitting Multiple Sclerosis","enrollment":50},{"nctId":"NCT01422317","phase":"PHASE3","title":"Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Helse Stavanger HF","startDate":"1995-09","conditions":"Coronary Disease, Myocardial Infarction","enrollment":300},{"nctId":"NCT00892684","phase":"NA","title":"Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease?","status":"UNKNOWN","sponsor":"Linkoeping University","startDate":"2003-03","conditions":"Allergies","enrollment":146}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":89,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Omacor-R"],"phase":"phase_3","status":"active","brandName":"EPA / DHA / Alpha-Tocopherol","genericName":"EPA / DHA / Alpha-Tocopherol","companyName":"Helse Stavanger HF","companyId":"helse-stavanger-hf","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A combination of omega-3 fatty acids (EPA and DHA) and vitamin E that reduces inflammation and oxidative stress to support cardiovascular and metabolic health. Used for Cardiovascular disease prevention or management (Phase 3 indication under investigation).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}